v2 Controlled Substance Schedule
activeContentcompleteURL
http://terminology.hl7.org/CodeSystem/v2-0477Copied!
Version2.9Copied!
PublisherHL7, IncDescriptionFHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)
Concepts
Select a concept to view details
Controlled Substance Schedule
{
"description" : "FHIR Value set/code system definition for HL7 v2 table 0477 ( Controlled Substance Schedule)",
"meta" : {
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablecodesystem" ]
},
"publisher" : "HL7, Inc",
"content" : "complete",
"property" : null,
"name" : "v2.0477",
"experimental" : false,
"resourceType" : "CodeSystem",
"title" : "v2 Controlled Substance Schedule",
"extension" : [ {
"valueCode" : "external",
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"
}, {
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 0
}, {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 6
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"language" : "en",
"id" : "86fad8ee-de99-4c0f-bf8e-632a08843507",
"url" : "http://terminology.hl7.org/CodeSystem/v2-0477",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.18.304"
} ],
"version" : "2.9",
"contact" : [ {
"telecom" : [ {
"system" : "url",
"value" : "http://hl7.org"
} ]
} ],
"text" : {
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>Controlled Substance Schedule</p>\n\n <table class=\"grid\">\n <tr>\n <td>\n <b>Code</b>\n </td>\n <td>\n <b>Description</b>\n </td>\n <td>\n <b>Comment</b>\n </td>\n <td>\n <b>Version</b>\n </td>\n </tr>\n <tr>\n <td>I\n <a name=\"I\"> </a>\n </td>\n <td>Schedule I</td>\n <td>Includes drugs that have a high potential for abuse, no currently accepted medical use in the United States and a lack of accepted safety for use under medical supervision.</td>\n <td>added v2.5</td>\n </tr>\n <tr>\n <td>II\n <a name=\"II\"> </a>\n </td>\n <td>Schedule II</td>\n <td>Includes drugs having currently accepted medical use in the United States and a high abuse potential, with severe psychological or physical dependence liability.</td>\n <td>added v2.5</td>\n </tr>\n <tr>\n <td>III\n <a name=\"III\"> </a>\n </td>\n <td>Schedule III</td>\n <td>Includes drugs having an abuse potential less than that of drugs listed in Schedules I and II. All CS III drugs have a currently accepted medical use in the United States.</td>\n <td>added v2.5</td>\n </tr>\n <tr>\n <td>IV\n <a name=\"IV\"> </a>\n </td>\n <td>Schedule IV</td>\n <td>Includes drugs having a lesser potential for abuse than those listed in Schedule III. CS IV drugs have a currently accepted medical use in the United States.</td>\n <td>added v2.5</td>\n </tr>\n <tr>\n <td>V\n <a name=\"V\"> </a>\n </td>\n <td>Schedule V</td>\n <td>Includes drugs having low abuse potential and limited physical or psychological dependence relative to those listed in IV and have an accepted medical use in the United States.</td>\n <td>added v2.5</td>\n </tr>\n <tr>\n <td>VI\n <a name=\"VI\"> </a>\n </td>\n <td>Schedule VI</td>\n <td>State defined</td>\n <td>added v2.5</td>\n </tr>\n </table>\n\n </div>",
"status" : "additional"
}
}